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Dopamine (DA) D3 receptor (D3R) is a pre-synaptic autoreceptor whose main role is to modulate DA release 
through a negative feedback regulatory loop. Immunolocalization studies from our research group have previously 
described that these receptors, despite being relatively low expressed in the central nervous system (CNS), may still 
be detected in less discreet brain regions normally associated to memory function, including the hippocampus and 
the cerebral cortex (1). Consistent with these findings, genetic deletion of the D3R in mice (D3R-/-) has been shown 
to have profound repercussions on the formation of new memories, especially fear associative memories (2). While 
it is now well-accepted that such pro-cognitive effects in these mice are presumably due to the increased DA bio-
availability caused by the lack of autoreceptor function, it still remains to be established if there are molecular deter-
minants directly or indirectly involved in ameliorating this specific type of associative learning. Pituitary adenylate 
cyclase-activating polypeptide (PACAP) is an endogenous peptide which is gaining scientific relevance because of 
its prominent “cognitive enhancer” function and the recent developments suggesting its active participation in the 
acquisition and consolidation of fear memories (3, 4). Based on these evidences, we thought it could have been of sci-
entific relevance to assess whether PACAP expression, as well as that of its binding receptors, are affected in knock-
out mice showing this peculiar behavioural phenotype. We found that PACAP immunoreactivity (IR) was present at 
low levels in CA1 hippocampal subfield while moderate staining was observed in CA2-CA3 fields and in the dentate 
gyrus (DG) of wild-type (WT) mice. In sharp contrast, PACAP-IR was remarkably increased in all CA subfields, and 
particularly in CA1, CA3 and the DG regions of D3R-/- mice. Regarding the cerebral cortex (CX), PACAP expression 
was restricted to the V cortical layer in WT mice, whereas in D3R-/- mice, stained neurons were apparent both in 
the IV, V and VI cortical layers, with an overall increased staining score. In line with these findings, the expression of 
the PACAP-preferring PAC1 receptor, which was detectable only at moderate levels in the CA2 subfield of WTs, was 
enhanced in both CA2 and CA3 of D3R-/- mice. Interestingly, PAC1-IR was already present at moderate levels in the 
II-III cortical layers of WT mice, but genetic deletion of the D3R caused a remarkable spread of PAC1-stained neurons 
throughout all cortical layers, with the exception of layer I. We conclude that the absence or blockade of functional 
D3Rs from the brain enhances both PACAP and PAC1 receptor expression levels in the hippocampus and cerebral 
cortex. Considering the ameliorative role mediated by PACAP-PAC1 signalling in cognition, we infer that enhanced 
PACAP peptide and receptor expression may relate to the specific behavioural phenotype of these mice. 
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